Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
1,900 results
  1. Breast Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65744
    ... patient data of 18,766 patients from 26 adjuvant trials of bisphosphonates of any type.[ 177 ] Overall, reductions ... early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. Lancet 389 (10075): 1195-1205, 2017. [ PMC free ...
  2. Rectal Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65965
    ... of a secondary analysis of a large scale adjuvant trial. Ann Surg 235 (4): 458-63, 2002. [ PMC ... of a secondary analysis of a large scale adjuvant trial. Ann Surg 235 (4): 458-63, 2002. [ PMC ...
  3. Colon Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65858
    ... of a secondary analysis of a large scale adjuvant trial. Ann Surg 235 (4): 458-63, 2002. [ PMC ... months.[ 25 ] Based on results from the MOSAIC trial, adjuvant FOLFOX-4 demonstrated prolonged OS for patients with ...
  4. Results - Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK310449
    ... risk of locoregional bladder cancer recurrence (SOE: moderate). Adjuvant Chemotherapy Four trials found adjuvant chemotherapy (AC) associated with decreased risk ...
  5. Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65869
    ... 1.66; P = .74). The Bile Duct Cancer Adjuvant Trial (BCAT), a Japanese multicenter phase III study, randomized ... All patients are encouraged to enroll in clinical trials for adjuvant therapies. Information about ongoing clinical trials is available ...
  6. Pancreatic Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65957
    ... U.S. Gastrointestinal Intergroup RTOG-0848 phase III adjuvant trial evaluating the impact of chemoradiation therapy after completion ... Neoptolemos JP, Dunn JA, Stocken DD, et al.: Adjuvant chemoradiotherapy and chemotherapy in ... 358 (9293): 1576-85, 2001. [ PubMed : 11716884 ] ...
  7. Mistletoe Extracts (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66054
    ... Kleeberg UR, Brocker EB, Lejeune F, et al.: Adjuvant trial in melanoma patients comparing rlFN-alpha to rlFN- ... 50; 14 Improved survival and tolerance to either adjuvant or palliative treatment Yes 1iiA [ 53 ] Nonrandomized controlled trial Isorel Digestive tract 70; 40; 30 Enhanced cellular ...
  8. Appendices - Early and locally advanced breast cancer: diagnosis and management - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK541650
    ... chemotherapy and trastuzumab. This was based on large adjuvant trials, which demonstrated that the addition of trastuzumab to ... Overall and disease free survival values for the adjuvant chemotherapy and ... results of the HERA trial (Cameron 2017). Hazard ratios (HRs) of 0.74 ...
  9. NLM Digital Collections - Pathological complete response in neoadjuvant treatment of high-risk early-stage breast ... 
    Publication: [Silver Spring, MD] : United States Food and Drug Administration, Oncology Center of Excellence, July 2020
    resource.nlm.nih.gov/9918227256906676
    ... issues may be mitigated by having a global adjuvant trial well underway at the time of accelerated approval. ... question, and ongoing or fully accrued large randomized adjuvant trials. The multiple trial model also may be appropriate ...
  10. Symptomatic pharmacological therapy in Parkinson’s disease - Parkinson's Disease - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK48523
    ... to recommendation The size and quality of the adjuvant selegiline trials was poor, so it is impossible to reach ... of COMT inhibitors ahead of dopamine agonists. Further trials are required to compare these classes of adjuvant therapy. 7.6.3. Dopamine agonists compared with ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last